<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">In addition to HIV, viral hepatitis remains an important global health issue, characterized by high prevalence, high burden of morbidity and mortality, and suboptimal diagnosis and management approaches [
 <xref ref-type="bibr" rid="CR8">8</xref>–
 <xref ref-type="bibr" rid="CR10">10</xref>]. Viral hepatitis are the most common viral infections affecting PWIDs [
 <xref ref-type="bibr" rid="CR10">10</xref>, 
 <xref ref-type="bibr" rid="CR11">11</xref>]. HIV and viral hepatitis infections share common transmission routes, risk behaviors and their co-infection represents a serious global concern resulting in high morbidity and mortality rates [
 <xref ref-type="bibr" rid="CR11">11</xref>, 
 <xref ref-type="bibr" rid="CR12">12</xref>]. HIV infection affects the natural course of hepatitis B virus (HBV) and hepatitis C virus (HCV), promoting faster progression to chronicity, liver fibrosis, and malignancy [
 <xref ref-type="bibr" rid="CR2">2</xref>, 
 <xref ref-type="bibr" rid="CR9">9</xref>–
 <xref ref-type="bibr" rid="CR11">11</xref>]. The BBS among PWID in Mozambique estimated HBV prevalence at 32.1 and 36.4%, and HCV prevalence at 44.6 and 7.0%, in Maputo and Nampula/Nacala respectively. Data about HBV and HCV among the general population in Mozambique is limited to a few studies in the southern region of the country [
 <xref ref-type="bibr" rid="CR13">13</xref>, 
 <xref ref-type="bibr" rid="CR14">14</xref>].
</p>
